Table 2

Passive permeability, active transport, and visual acuity in eyes with succesfull photocoagulation—that is, without CSMO at follow up (n = 23, responding eyes) and eyes where CSMO was still present at follow up (n = 23, non-responding eyes). For comparison, data from eyes without CSMO both at baseline and follow up (n=11) are included

Passive permeability nm/s baseline/follow upActive transport nm/s baseline/follow upVisual acuity logMAR baseline/follow up
*Significant difference (t test) between responding and non-responding eyes at follow up. †Significant differences (t test) between eyes without CSMO and both groups of CSMO eyes (that is, both responding and non-responding eyes). ‡The significant difference between eyes without CSMO and non-responding eyes with persistent CSMO at follow up.
CSMO at baseline no CSMO at follow up
    Mean8.23/7.44*66.82/63.070.08/0.05*
    95% confidence interval5.5 to 12/5.1 to 1142 to 107/43 to 930.02 to 0.14/0.01 to 0.09
CSMO at baseline still CSMO at follow up
    Mean12.26/13.4967.53/95.150.18/0.33
    95% confidence interval8.4 to 18/9.5 to 1954 to 112/72 to 1250.07 to 0.30/0.21 to 0.46
No CSMO at baseline and follow up
    Mean3.67†/3.95‡86.78/85.660.04/0.04‡
    95% confidence interval2.6 to 5.1/2.7 to 5.963 to 119/60 to 121−0.1 to 1.7/−0.08 to 1.7